FSN E-Commerce Ventures Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 12:38 am

Quick Insight

FSN E-Commerce Ventures Ltd's current market cap stands at a substantial ₹66,268 Cr., yet its P/E ratio is notably high at 831, indicating a potentially overvalued stock. With a ROE of 5.16% and ROCE of 9.59%, the company's profitability and capital efficiency seem modest. However, the OPM of 7% raises concerns about operational efficiency. The company's high P/BV ratio of 39.34x suggests an inflated stock price compared to its book value. Moreover, the significant borrowings of ₹1,321 Cr. alongside a CCC of 75 days may pose liquidity risks. Investors should exercise caution, considering these metrics point to potential overvaluation and financial leverage issues for FSN E-Commerce Ventures Ltd.

Competitors of FSN E-Commerce Ventures Ltd

All Competitor Stocks of FSN E-Commerce Ventures Ltd

Quarterly Result

Last Updated: August 19, 2025, 3:10 pm

Below is a detailed analysis of the quarterly data for FSN E-Commerce Ventures Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,155.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,062.00 Cr. (Mar 2025) to 2,155.00 Cr., marking an increase of 93.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,014.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,928.00 Cr. (Mar 2025) to 2,014.00 Cr., marking an increase of 86.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 133.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 8.00 Cr..
• For OPM %, as of Jun 2025, the value is 7.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2025) to 7.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Interest, as of Jun 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 30.00 Cr..
• For Depreciation, as of Jun 2025, the value is 76.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 73.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 44.00%. The value appears to be improving (decreasing) as expected. It has decreased from 52.00% (Mar 2025) to 44.00%, marking a decrease of 8.00%.
• For Net Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 5.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.08. The value appears strong and on an upward trend. It has increased from 0.07 (Mar 2025) to 0.08, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 1:06 pm

Growth

Last Updated: September 5, 2025, 3:30 pm

Balance Sheet

Last Updated: August 11, 2025, 3:59 pm

Below is a detailed analysis of the balance sheet data for FSN E-Commerce Ventures Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 286.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 286.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 977.00 Cr. (Mar 2024) to 1,015.00 Cr., marking an increase of 38.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,321.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 969.00 Cr. (Mar 2024) to 1,321.00 Cr., marking an increase of 352.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,358.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,169.00 Cr. (Mar 2024) to 1,358.00 Cr., marking an increase of 189.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,980.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,401.00 Cr. (Mar 2024) to 3,980.00 Cr., marking an increase of 579.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 835.00 Cr.. The value appears strong and on an upward trend. It has increased from 668.00 Cr. (Mar 2024) to 835.00 Cr., marking an increase of 167.00 Cr..
• For CWIP, as of Mar 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2024) to 37.00 Cr., marking an increase of 7.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 34.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,108.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,668.00 Cr. (Mar 2024) to 3,108.00 Cr., marking an increase of 440.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,980.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,401.00 Cr. (Mar 2024) to 3,980.00 Cr., marking an increase of 579.00 Cr..

However, the Borrowings (1,321.00 Cr.) are higher than the Reserves (1,015.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for FSN E-Commerce Ventures Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 5. It has increased from 0.11 (Mar 24) to 0.23, marking an increase of 0.12.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 5. It has increased from 0.11 (Mar 24) to 0.23, marking an increase of 0.12.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 3. It has increased from 0.93 (Mar 24) to 1.19, marking an increase of 0.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.55. It has increased from 4.42 (Mar 24) to 4.55, marking an increase of 0.13.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.55. It has increased from 4.42 (Mar 24) to 4.55, marking an increase of 0.13.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 27.80. It has increased from 22.36 (Mar 24) to 27.80, marking an increase of 5.44.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 2. It has increased from 1.32 (Mar 24) to 1.75, marking an increase of 0.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.82. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 0.82, marking an increase of 0.29.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.44. This value is within the healthy range. It has increased from 0.24 (Mar 24) to 0.44, marking an increase of 0.20.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 2. It has increased from 0.15 (Mar 24) to 0.25, marking an increase of 0.10.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 2. It has increased from 0.11 (Mar 24) to 0.23, marking an increase of 0.12.
• For PBDIT Margin (%), as of Mar 25, the value is 6.30. This value is below the healthy minimum of 10. It has increased from 5.88 (Mar 24) to 6.30, marking an increase of 0.42.
• For PBIT Margin (%), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 10. It has increased from 2.37 (Mar 24) to 2.95, marking an increase of 0.58.
• For PBT Margin (%), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 10. It has increased from 1.08 (Mar 24) to 1.60, marking an increase of 0.52.
• For Net Profit Margin (%), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 5. It has increased from 0.68 (Mar 24) to 0.92, marking an increase of 0.24.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 8. It has increased from 0.50 (Mar 24) to 0.83, marking an increase of 0.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 15. It has increased from 2.55 (Mar 24) to 5.07, marking an increase of 2.52.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.90. This value is within the healthy range. It has increased from 9.97 (Mar 24) to 12.90, marking an increase of 2.93.
• For Return On Assets (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 5. It has increased from 0.94 (Mar 24) to 1.66, marking an increase of 0.72.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.08, marking an increase of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.73. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 0.73, marking an increase of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.15. It has increased from 2.01 (Mar 24) to 2.15, marking an increase of 0.14.
• For Current Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 1.5. It has increased from 1.22 (Mar 24) to 1.24, marking an increase of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.58.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 4. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.67. This value is within the healthy range. It has increased from 4.54 (Mar 24) to 4.67, marking an increase of 0.13.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 3. It has increased from 1.53 (Mar 24) to 1.69, marking an increase of 0.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 51,981.36. It has increased from 46,697.83 (Mar 24) to 51,981.36, marking an increase of 5,283.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.54. This value exceeds the healthy maximum of 3. It has decreased from 7.31 (Mar 24) to 6.54, marking a decrease of 0.77.
• For EV / EBITDA (X), as of Mar 25, the value is 103.72. This value exceeds the healthy maximum of 15. It has decreased from 124.17 (Mar 24) to 103.72, marking a decrease of 20.45.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.44. This value exceeds the healthy maximum of 3. It has decreased from 7.24 (Mar 24) to 6.44, marking a decrease of 0.80.
• For Price / BV (X), as of Mar 25, the value is 39.34. This value exceeds the healthy maximum of 3. It has increased from 36.65 (Mar 24) to 39.34, marking an increase of 2.69.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.44. This value exceeds the healthy maximum of 3. It has decreased from 7.24 (Mar 24) to 6.44, marking a decrease of 0.80.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness